Vélez-Reyes, G.L.; Koes, N.; Ryu, J.H.; Kaufmann, G.; Berner, M.; Weg, M.T.; Wolf, N.K.; Rathe, S.K.; Ratner, N.; Moriarity, B.S.;
et al. Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. Cancers 2021, 13, 1584.
https://doi.org/10.3390/cancers13071584
AMA Style
Vélez-Reyes GL, Koes N, Ryu JH, Kaufmann G, Berner M, Weg MT, Wolf NK, Rathe SK, Ratner N, Moriarity BS,
et al. Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. Cancers. 2021; 13(7):1584.
https://doi.org/10.3390/cancers13071584
Chicago/Turabian Style
Vélez-Reyes, Germán L., Nicholas Koes, Ji Hae Ryu, Gabriel Kaufmann, Mariah Berner, Madison T. Weg, Natalie K. Wolf, Susan K. Rathe, Nancy Ratner, Branden S. Moriarity,
and et al. 2021. "Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development" Cancers 13, no. 7: 1584.
https://doi.org/10.3390/cancers13071584
APA Style
Vélez-Reyes, G. L., Koes, N., Ryu, J. H., Kaufmann, G., Berner, M., Weg, M. T., Wolf, N. K., Rathe, S. K., Ratner, N., Moriarity, B. S., & Largaespada, D. A.
(2021). Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. Cancers, 13(7), 1584.
https://doi.org/10.3390/cancers13071584